09.03.2010TIME: 17:35:00
LAST
16,39 €
OPEN
16,10 €
CHANGE
+3,34%»
COMPANY PIPELINE NEWS INVESTOR RELATIONS   Search
 
mission statement


 
COMPANY COMPANY
  ThromboGenics is a leading biopharmaceutical company focused on the discovery and development of novel therapeutics for diseases related to... more »  
 
English
Nederlands
English
Nederlands
COMPANY
PIPELINE PIPELINE
  ThromboGenics has developed a strong pipeline of products for the treatment of a broad range of conditions related to the vasculature, including visual disorders, ... more »  
  foto2 Pipeline overview
NEWS & EVENTS NEWS & EVENTS
 

February 9, 2010

ThromboGenics - Positive Microplasmin Phase II data published in Ophthalmology... more »

ThromboGenics - Publicatie van positieve resulaten in Fase II studie met Microplasmine in Ophthalmology..meer »

 
  All rights reserved © ThromboGenics 2006 Last update: February 9, 2010 Inspired by Echo
 
PIPELINE COMPANY Pipeline overview